GlassScriptPhysician profile
Alexandra Gentry
NPI 1447919444
$1,518.56
in general payments reported to CMS, 2019-2025
14 companies · $214 in 2025
The $214 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $80.07 · 2023: $477 · 2024: $748 · 2025: $214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,438.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,438.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $240.07 | 2024 | Erleada, Akeega |
| Ferring Pharmaceuticals INC. | $195.82 | 2024-2025 | Adstiladrin |
| Abbvie INC. | $180.45 | 2023-2025 | |
| Endo Pharmaceuticals INC. | $168.13 | 2022-2024 | Xiaflex, Aveed |
| Convatec INC. | $152.41 | 2024 | |
| 180 Medical, INC. | $135.89 | 2023-2024 | Gentlecath, Cure Ultra Catheter, Cure Catheter |
| Astellas Pharma US INC | $111.55 | 2022-2023 | Myrbetriq |
| Sumitomo Pharma America, INC. | $74.88 | 2023-2024 | Gemtesa |
| Telix Pharmaceuticals | $64.92 | 2023-2025 | Illuccix |
| Boston Scientific Corporation | $51.38 | 2023-2025 | Rezum Generator, Accolade Sr |
| Endo USA, INC. | $48.48 | 2024 | Xiaflex, Aveed |
| Medtronic, INC. | $41.97 | 2023-2024 | Interstim |
| Progenics Pharmaceuticals, INC. | $27.65 | 2023 | Pylarify |
| C. R. Bard, INC. & Subsidiaries | $24.96 | 2024 | Bard Urinary Drainage Bag |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexandra Gentry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.